arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CATALYST PHARMACEUTICALS, INC.

CPRX
$31.49 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
75 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
90
Health
Excellent
Bullish
auto_awesome

Analytical Summary

CATALYST PHARMACEUTICALS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $3.8B
Dividend Yield
Revenue Growth 5.6%
Op. Margin 49.0%
ROIC 5.5%
FCF / Share $0.49
Trailing P/E 60.6x
Price / Book 3.8x
FCF Yield 1.6%
Debt / Equity
info Valuation on last close. End-of-day price, Jul 14, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$149.39M
↑ +5.6%
Net Income Profit after all expenses
$63.73M
↑ +12.3%
Operating Margin Operating profit as % of sales
49.0%
↑ +21.0% 95th
FCF / Share Free cash flow per share
$0.49
↓ -1.4%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
95
Returns
88
Financial Health
98
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 25 years · 75 quarters